Illumina Inc.
Illumina Inc (ILMN) is a leading provider of DNA sequencing and genotyping systems, reagents and software used by academic, clinical and commercial customers worldwide. Its platforms power genomic research, diagnostics, oncology profiling and prenatal testing, linking instrument sales with recurring consumable revenue. Key growth drivers include rising demand for personalised medicine, falling sequencing costs and expansion of clinical sequencing programmes. Investors should note significant risks: intense competition, evolving regulation for diagnostic use, patent and legal disputes, and revenue sensitivity to research funding cycles. With a market capitalisation around $15.2bn, Illumina is a growth-oriented business that can offer exposure to the structural trend of genomics but can also experience volatility and periodic setbacks. This summary provides general, educational information only and is not personal financial advice; prospective investors should research fundamentals, consider risk tolerance and seek professional advice where appropriate.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Illumina's stock as they believe it has good potential for growth.
Financial Health
Illumina is successfully generating strong revenue and cash flow, indicating a healthy business performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring ILMN
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketThe Alzheimer's Treatment Ecosystem
Following the EU regulator's approval of Eli Lilly's Alzheimer's drug, Kisunla, a new investment opportunity has emerged. This theme focuses on companies that provide essential support services, such as genetic testing and advanced imaging, which are crucial for the drug's administration and monitoring.
Published: July 27, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketSynthetic-Bio Foundries
Discover companies that are programming living cells to create the materials of tomorrow. These carefully selected stocks represent pioneers in replacing petrochemical processes with cleaner, more efficient biological alternatives - essentially turning microbes into tiny manufacturing plants.
Published: June 17, 2025
Explore BasketPatient Platforms
This carefully curated collection features companies building the technological foundations that will power innovation for decades to come. Our analysts have identified businesses creating essential infrastructure in genomics, AI, robotics, and advanced computing—platforms that could define their industries and generate substantial long-term returns.
Published: June 17, 2025
Explore BasketTop Biotech Stocks
Discover companies at the forefront of medical breakthroughs and healthcare innovation. This collection of biotech stocks has been carefully selected by our professional analysts for their growth potential and contributions to revolutionary treatments.
Published: May 29, 2025
Explore BasketPharma
Health is wealth, and these carefully selected pharmaceutical companies could help your portfolio grow. Our professional analysts have handpicked these stocks from an industry that's projected to reach $1.9 trillion by 2027.
Published: May 6, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Genomics Growth Trend
Sequencing demand is rising as research and clinical applications expand; this structural tailwind can support long-term growth, though revenue can be cyclical.
Clinical Adoption Rising
Greater use of genomics in diagnostics and oncology broadens addressable markets, but clinical regulation and reimbursement affect pace of adoption.
IP & Regulatory Factors
Patent disputes and evolving regulatory rules materially affect outlook; they can create volatility and should be monitored by interested investors.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
